|
|
Hepatitis Is An Inflammation Of The Liver Which Can Be Caused By Bacterial Or Viral Infection, Parasitic Infestation, Alcohol, Drugs, Toxins, Or Transfusion Of Incompatible Blood. We Are Here To Educate You About Hepatitis. Welcome To Hepatitis Insights. This Site Is Your Free Information Resource That Will Answer All Of Your Questions About Hepatitis.
As You Explore This Site, You'll Discover...
|
|
Hepatitis FAQ: The Seven Most Asked Questions About Hepatitis |
Revealed: Are There Any Treatment Options For Hepatitis C? |
Our Look At The Causes, Symptoms, And Treatments Of Hepatitis |
A Patient Asks: Is There Really Life After Contracting Hepatitis C? |
|
Remember... If You Are Looking For Quality Information Related To Hepatitis, Add This Site To Your Favorites Right Now, As We Update It Daily With The Latest News And Information Related To Hepatitis And Similar Topics. Enjoy The Site.
Everything You Must Know About Hepatitis C Transmission, Hep C Symptoms, Hepatitis C Education, Hepatitis C Treatment, Cure For Hep C, Hep C Treatments, And Treatment For Hepatitis C.
|
|
| Latest Related Articles
About Hepatitis |
|
Hepatitis C |
|
Are you experiencing jaundice, fatigue, dark urine, abdominal pain, loss of appetite, and nausea? If you experience all these, you can be suffering from hepatitis C, a disease of the liver, which is caused by the hepatitis C virus or HCV. This disease is transmitted when the blood from an infected person enters the body of an uninfected person. It can be spread through sharing needles. It can also be transmitted from an infected mother to her baby during birth. The long-term effects of this disease include chronic infection, chronic liver disease, and death. Unlike other diseases, hepatitis C has no vaccine, but there are blood tests that are available to check for this disease,... |
|
|
The Risks Of Piercing And Tattooing |
|
(NC)-If you plan to get a tattoo, or body piercing, you should know that there is a risk of getting hepatitis C from old, unsterile tattooing needles that have been used on more than one customer, or from unsterile practice by the tattoo artist (i.e. licking the tattooing needle, using the same ink or ink containers for more than one person, or testing needle sharpness by pricking his/her hand.) Body piercing also poses a risk of hepatitis C transmission since it involves the use of needles and possible exposure to blood. If needles and other piercing equipment are not adequately sterilized between customers, they could be a source of hepatitis C infection. Don't let anyone use... |
|
|
Types of Hepatitis |
|
Hepatitis is a disease taking on many forms which feature inflammation of the liver. The cause is depended on the prognosis and on the symptoms shown. Certain forms of hepatitis are unable to reveal many signs or symptoms and are only noticeable when the longstanding inflammation has led to the replacement of liver cells by connective tissue. General symptoms of hepatitis are noticed by fever, enlarged liver, abdominal pain, and jaundice (icterus). Viral infections are the cause of most acute Hepatitis . Hepatitis comes in 7 not so delicious flavours: Hepatitis A, B, C, D - Agent (which requires the presence of the hepatitis B virus to form), Hepatitis E, F, and G. None of these are... |
|
|
| Looking For More Articles Related To Hepatitis? |
Hepatitis C Transmission Poll |
|
|
| |
|
| |
| |
| |
Translate/Traduisez/Übersetzen Sie/Traduzca/Traduca/Traduza:
Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)
Author:
ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN
Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)
ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN
Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China
Research Method:
Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.
Number of cases: 25 (n)
Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1×104 cp/mL.
Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1×104 - 1×107-8, HBV-DNA, unit of measurement is cp/mL.
Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.
Observation index:
- HBV-DNA response after the treatment.
- Lasting HBV-DNA response (six months after withdrawal).
Criterion of Therapeutic Effect:
- If HBV-DNA volume 1×104 cp/mL: 4/25 (16%)
- Lasting response:
HBV-DNA volume 1×104 cp/mL: 2/25 (8%)
Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1×102 cp/mL). The testing range of this testing method is 1×102 - 1×107-8 cp/mL.
Conclusion
The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient’s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.
Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.
* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.
For more information, please visit: http://www.vigconic.com
Or, contact:
William Yip cs@vigconic.com
5/F, Cheung Wah Building, Sheung Heung Rd,
Kowloon, Hong Kong
Tel: 852-27656200
Fax: 852-27645314
Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China
webmaster@vigconic.com
Translate/Traduisez/Übersetzen Sie/Traduzca/Traduca/Traduza:
Article Keywords:
Hepatitis |
|
A Quick Note
From The Publisher...
If you like the article above, you may be
interested in the following article which is also related to Hepatitis...
|
Hepatitis C Virus |
|
Hepatitis C is one of the seven types of hepatitis, a disease that takes on many forms and features inflammation of the liver. Although this type does not reveal many signs or symptoms, there are various treatments that can be used to cure this disease, one of which is a combination of interferon alfa injections and ribavirin capsules. But for mild hepatitis C, doctors will recommend bed rest, a healthy diet, and some medications after diagnosis. Hepatitis C is diagnosed through a blood test to determine the severity of the disease. In the case of chronic hepatitis, the illness can be assessed through a tissue sample from the liver. Aside from this, there are many other tests for liver function that can be conducted to determine to what extent the liver is affected by the hepatitis C virus. In 1989, investigators at Chiron, Inc., discovered the hepatitis C virus, better known as HCV. This is an enveloped, single-stranded, positive sense RNA virus of the Hepacivirus genus and Flaviviridae family. This virus binds to receptors, the CD81 and Scavenger Receptor class b1, on liver tissue when circulating in the bloodstream. Based on genetic differences, HCV is classified into six genotypes that can be transmitted by blood contact. Unlike hepatitis A and B, there is no vaccine for hepatitis C. But there are available treatments that may vary depending on the HCV genotype. In spite of the discovery of HCV, much experimentation should still be done in order to come up with drugs to better treat this disease. Even with the development of excellent diagnostic methods, the production of specific drugs that work against HCV is yet to come. But with the advancement in science and technology, they soon will be discovered. Hepatitis C provides detailed information on... |
|
|
|
|
|
|
Hepatitis, Hep C Symptoms News |
BioLineRx In-Licenses Second Oral Hepatitis C Treatment BioLineRx  , a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C. Hepatitis Research May Benefit From Stem Cells Hepatitis C is a viral disease that leads to inflammation and organ failure. However, researchers are puzzled as to why some individuals are very susceptible to the disease, while others are not. Researchers believe they could find out how genetic variations produce these different responses by investigating liver cells from different individuals in the lab. However, liver cells are hard to ... BioLineRX soars on second hepatitis C deal BOSTON (MarketWatch) -- Shares of BioLineRx soared 33% to $5.49 on Monday on news that the Israeli drug developer has licensed an experimental treatment for hepatitis C, dubbed BL-8030, from Genoscience and RFS Pharma. The agent, which belongs to a class of drugs called NS3 protease inhibitors, has yet to begin human clinical trials. Last month, BioLineRx licensed another preclinical hepatitis C ... Township hosting hepatitis B vaccine clinics WEST MILFORD Hepatitis is one of the most harmful diseases one can have, many times leading into liver cancer years down the road. The West Milford Health Department is promoting a series of three hepatitis B vaccines to protect your liver from this devastating disease. Gilead Sciences jumps on hepatitis C data Shares of Gilead Sciences Inc. jumped Friday after the company reported further progress of GS-7977, a newly-acquired hepatitis C treatment still in clinical testing.THE SPARK: Gilead said Thursday that ... U.S. hepatitis A vaccine rates vary widely, survey shows NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC). In certain states, particularly those in the south, midwest and eastern U.S., those rates are lower -- with about three kids out of 10 ... |
|
|
|
